2020 Global life sciences outlook
Creating new value | Building blocks for the future
Gene therapies, intelligent drug discovery and development, consumer wearables, telemedicine, and more—what are some of the drivers transforming the life sciences sector? How can biopharma and medtech organizations create new value in 2020, while tackling various challenges?
2020 Global Health Care Outlook
Laying a foundation for the future
Rising health care costs. Changing patient demographics. Evolving consumer expectations. New market entrants. Complex health and technology ecosystems.
Implementation of Track&Trace solutions in Russia
Deloitte CIS held a business breakfast at its Moscow office on 13 August to discuss the key issues in Track &Trace solutions for pharmaceuticals and consumer products in Russia.
Health & Wellness Progress Report
Based on 2018 survey findings
The latest Health & Wellness Progress Report, created in collaboration with The Consumer Goods Forum (CGF), sees a progressive shift in how its members are working together to address the issues that matter the most to their consumers.
Digital strategy: building digital bridges to end consumers
Russian Pharmaceutical Market Trends in 2018
The challenge of compliance in the life sciences supply chain
In an environment driven by increasing complexity, product diversity and regulatory scrutiny, what are the major compliance risks impacting the entirety of the life sciences supply chain? What opportunities exist to transform compliance from a burden to a source of competitive advantage?